145370-39-4 | 2-(3-Methoxy-4-nitrophenyl)-4h-chromen-4-one

Packsize	Purity	Availability	Price	Discounted Price
100mg	95%	in stock	$353.00	$247.00

Description

• Catalog Number: AB45016
• Chemical Name: 2-(3-Methoxy-4-nitrophenyl)-4h-chromen-4-one
• CAS Number: 145370-39-4
• Molecular Formula: C16H11NO5
• Molecular Weight: 297.2622
• MDL Number: MFCD22479198
• SMILES: COc1cc(ccc1[N+](=O)[O-])c1cc(=O)c2c(o1)cccc2

Computed Properties

• Complexity: 483
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 22
• Hydrogen Bond Acceptor Count: 5
• Rotatable Bond Count: 2
• XLogP3: 3.4

Literature

• The highly bioactive molecule and signal substance 6-formylindolo[3,2-b]carbazole (FICZ) plays bi-functional roles in cell growth and apoptosis in vitro.

  Archives of toxicology 20171001

• Aryl hydrocarbon receptor signaling modifies Toll-like receptor-regulated responses in human dendritic cells.

  Archives of toxicology 20170501

• Environmental pollutants parathion, paraquat and bisphenol A show distinct effects towards nuclear receptors-mediated induction of xenobiotics-metabolizing cytochromes P450 in human hepatocytes.

  Toxicology letters 20151001

• Activation of the aryl hydrocarbon receptor by the widely used Src family kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine (PP2).

  Archives of toxicology 20150801

• Aryl hydrocarbon receptor-dependent cell cycle arrest in isolated mouse oval cells.

  Toxicology letters 20131023

• Long interspersed element-1 is differentially regulated by food-borne carcinogens via the aryl hydrocarbon receptor.

  Oncogene 20131010

• Regulation of estrogen sulfotransferase expression by confluence of MCF10A breast epithelial cells: role of the aryl hydrocarbon receptor.

  The Journal of pharmacology and experimental therapeutics 20111101

• Suppression of WIF-1 through promoter hypermethylation causes accelerated proliferation of the aryl hydrocarbon receptor (AHR) overexpressing MCF10AT1 breast cancer cells.

  Toxicology 20110729

• Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism.

  The Journal of pharmacology and experimental therapeutics 20110701

• Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E-/- mice.

  Arteriosclerosis, thrombosis, and vascular biology 20110601

• FRET analysis of protein tyrosine kinase c-Src activation mediated via aryl hydrocarbon receptor.

  Biochimica et biophysica acta 20110401

• The AhR is constitutively activated and affects granulosa cell features in the human cell line KGN.

  Molecular human reproduction 20110201

• Species-specific differential AhR expression protects human neural progenitor cells against developmental neurotoxicity of PAHs.

  Environmental health perspectives 20101101

• CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor.

  Toxicological sciences : an official journal of the Society of Toxicology 20101001

• Cytochrome P450 1A1 gene regulation by UVB involves crosstalk between the aryl hydrocarbon receptor and nuclear factor kappaB.

  Chemico-biological interactions 20100330

• Arylhydrocarbon receptor activation in NCI-H441 cells and C57BL/6 mice: possible mechanisms for lung dysfunction.

  American journal of respiratory cell and molecular biology 20100201

• TCDD-induced cyclooxygenase-2 expression is mediated by the nongenomic pathway in mouse MMDD1 macula densa cells and kidneys.

  Biochemical pharmacology 20100201

• Antagonism of aryl hydrocarbon receptor signaling by 6,2',4'-trimethoxyflavone.

  The Journal of pharmacology and experimental therapeutics 20100101

• Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.

  Molecular endocrinology (Baltimore, Md.) 20100101

• The arylhydrocarbon receptor is only marginally involved in the antileukemic effects of its ligand curcumin.

  Anticancer research 20091101

• The conversion of rapid TCCD nongenomic signals to persistent inflammatory effects via select protein kinases in MCF10A cells.

  Molecular endocrinology (Baltimore, Md.) 20090401

• Characterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR).

  BMC cancer 20090101

• Significance of the nongenomic, inflammatory pathway in mediating the toxic action of TCDD to induce rapid and long-term cellular responses in 3T3-L1 adipocytes.

  Biochemistry 20081230

• Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase.

  Biochemical and biophysical research communications 20081024

• Roles of cytosolic phospholipase A2 and Src kinase in the early action of 2,3,7,8-tetrachlorodibenzo-p-dioxin through a nongenomic pathway in MCF10A cells.

  Molecular pharmacology 20080701

• Molecular determinants of species-specific agonist and antagonist activity of a substituted flavone towards the aryl hydrocarbon receptor.

  Archives of biochemistry and biophysics 20080415

• Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression.

  The American journal of pathology 20071101

• Cigarette smoke condensate and dioxin suppress culture shock induced senescence in normal human oral keratinocytes.

  Oral oncology 20070801

• beta-Naphthoflavone and 3'-methoxy-4'-nitroflavone exert ambiguous effects on Ah receptor-dependent cell proliferation and gene expression in rat liver 'stem-like' cells.

  Biochemical pharmacology 20070515

• Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation.

  Carcinogenesis 20070301

• Lack of the aryl hydrocarbon receptor leads to impaired activation of AKT/protein kinase B and enhanced sensitivity to apoptosis induced via the intrinsic pathway.

  The Journal of pharmacology and experimental therapeutics 20070101

• Impact of the arylhydrocarbon receptor on eugenol- and isoeugenol-induced cell cycle arrest in human immortalized keratinocytes (HaCaT).

  Biological chemistry 20060901

• Aryl hydrocarbon receptor- and calcium-dependent induction of the chemokine CCL1 by the environmental contaminant benzo[a]pyrene.

  The Journal of biological chemistry 20060721

• Human endothelial progenitors constitute targets for environmental atherogenic polycyclic aromatic hydrocarbons.

  Biochemical and biophysical research communications 20060317

• The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen.

  Cancer research 20060215

• The aryl hydrocarbon receptor is a regulator of cigarette smoke induction of the cyclooxygenase and prostaglandin pathways in human lung fibroblasts.

  American journal of physiology. Lung cellular and molecular physiology 20050901

• Human CD34-positive hematopoietic stem cells constitute targets for carcinogenic polycyclic aromatic hydrocarbons.

  The Journal of pharmacology and experimental therapeutics 20050801

• Superinduction of CYP1A1 in MCF10A cultures by cycloheximide, anisomycin, and puromycin: a process independent of effects on protein translation and unrelated to suppression of aryl hydrocarbon receptor proteolysis by the proteasome.

  Molecular pharmacology 20041001

• Dioxin-induced immortalization of normal human keratinocytes and silencing of p53 and p16INK4a.

  The Journal of biological chemistry 20040625

• Presence and functional activity of the aryl hydrocarbon receptor in isolated murine cerebral vascular endothelial cells and astrocytes.

  Neurotoxicology 20040601

• TCDD administration after the pro-adipogenic differentiation stimulus inhibits PPARgamma through a MEK-dependent process but less effectively suppresses adipogenesis.

  Toxicology and applied pharmacology 20040401

• 3'-methoxy-4'-nitroflavone, a reported aryl hydrocarbon receptor antagonist, enhances Cyp1a1 transcription by a dioxin responsive element-dependent mechanism.

  Archives of biochemistry and biophysics 20030801

• Species-specific transcriptional activity of synthetic flavonoids in guinea pig and mouse cells as a result of differential activation of the aryl hydrocarbon receptor to interact with dioxin-responsive elements.

  Molecular pharmacology 20030401

• The aryl hydrocarbon receptor antagonist, 3'methoxy-4'nitroflavone, attenuates 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent regulation of growth factor signaling and apoptosis in the MCF-10A cell line.

  Toxicology and applied pharmacology 20030401

• Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by resveratrol in breast cancer cells.

  Biochemical pharmacology 20011015

• In vivo antagonism of AhR-mediated gene induction by 3'-methoxy-4'-nitroflavone in TCDD-responsive lacZ mice.

  Toxicological sciences : an official journal of the Society of Toxicology 20010601

• Aryl hydrocarbon receptor signaling plays a significant role in mediating benzo[a]pyrene- and cigarette smoke condensate-induced cytogenetic damage in vivo.

  Carcinogenesis 20010101

• Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor.

  Carcinogenesis 19990801

• Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists.

  Biochemical pharmacology 19960426